Clinical Trial Update: A Feasibility and Safety Study of Concomitant Therapy With Allo-CAR-T Cells and Allo-HSCT in Patients With Relapse or Refractory Leukemia [Phase 1]

View source ↗

Summary

This clinical trial update covers a Phase 1 feasibility and safety study evaluating concomitant therapy with allogeneic CAR-T cells and allogeneic HSCT in patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Leukemia

Drugs mentioned

• Allo-CAR-T cells (allogeneic CAR-T cells)
• Allogeneic hematopoietic stem cell transplantation

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: B Cell Leukemia | Phase 1 | Status: UNKNOWN